Richard Kraig, MD PhD

William D. Mabie Professor in the Neurosciences, Neurology and Neurobiology, Pharmacology & Physiology

Assistant:  
Telephone: 773-702-0802
Patient Calls: 773-702-6222
Fax: 773-834-5435
Email: Assistant:
Lab Website: http://kraiglab.uchicago.edu
   

Dr. Richard Kraig is an expert in migraine patient care, migraine research and cerebrovascular disease research. His clinical interests focus on the diagnosis and treatment of migraine headaches. He oversees the Cerebrovascular Disease and Aging Laboratories, which focus on migraine, stroke, epilepsy and cognitive decline from aging.

An active researcher, Dr. Kraig leads investigations to determine how physical, mental and social activities can lessen the impact of neurological disease. Examination of such mechanisms by which the brain naturally protects itself may lead to more selective cellular and molecular targets, as well as new therapeutic strategies against brain disease. Dr. Kraig's research helps him to develop individualized treatment plans for patients in the Migraine Headache Clinic. He is also involved in teaching medical students, graduate students and residents.

Education & Training
  • Residency: Cornell Medical College
  • Internship: The University of Chicago Medicine
  • M.D.: New York University
  • Ph.D.: University of Iowa
Board Certification
  • Neurology, American Board of Psychiatry and Neurology
Clinical Interests
  • Migraine headaches
  • Neurology
  • Headaches
  • Cerebrovascular disease
Research Interests
  • An active researcher, Dr. Kraig oversees the Cerebrovascular Disease and Aging Laboratories. Increasing evidence indicates that enhanced physical, mental, and social activity can prevent neurological injury. Dr. Kraig and his coworkers seek to understand the basic mechanisms by which brain can protect itself against neurological disease via these activities. This knowledge can serve as a potent base for neurological preventative health strategies. Examination of the mechanisms by which the brain naturally protects itself may lead to more selective cellular and molecular targets for the development of new treatments against brain disease. The lab focuses on migraine, stroke, epilepsy, and cognitive decline from aging. Knowledge from the laboratory helps Dr. Kraig individualize treatment strategies in the clinic.
Society Memberships
  • American Academy of Neurology
  • American Headache Society
  • American Neurological Association
  • International Dose-Response Society
  • National Institutes of Health--periodic member of peer review study sections
  • Society for Neuroscience
Selected Internet Migraine Publications
Selected Publications